Literature DB >> 34405095

The Spectrum of Movement Disorders in Cases with Osmotic Demyelination Syndrome.

Dodmalur Mallikarjuna Sindhu1, Vikram V Holla1, Shweta Prasad1,2, Nitish Kamble1, Manjunath Netravathi1, Ravi Yadav1, Pramod K Pal1.   

Abstract

BACKGROUND: Osmotic demyelination syndrome (ODS) can be a central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM) based on the regions involved even though they share the same disease process, aetiopathogenesis and time course.
OBJECTIVES: Present study aims to characterize the clinical, radiological features and the outcome of patients with ODS with movement disorders as the forthcoming manifestation.
METHODS: Chart review of patients with ODS with movement disorders. Demographic, clinical and radiological details of the patients were reviewed.
RESULTS: Eleven patients (six females; mean age: 48.3 ± 17.6 years) were included in the study. Parkinsonism alone and parkinsonism with dystonia was noted in four patients each (36.4%) while dystonia alone was noted in the other 3 (27.3%). Five patients (45.5%) had postural tremors. While 5 patients had dystonia early in the course of illness (3-7 days), it was delayed (6-9 months) in the other 2. A triphasic course was noted in two patients. The first phase of hyponatremia induced neurological impairment was followed by a second phase of worsening due to the immediate effect of ODS and a third delayed phase of worsening due to delayed effect of ODS. MRI showed both EPM and CPM in eight patients, EPM alone in two patients and CPM alone in 1 patient. Nine patients had a good outcome with mRS < 3.
CONCLUSION: Parkinsonism and dystonia are important manifestations of ODS. Triphasic course with a delayed phase of worsening of movement disorders is probably due to the maladaptive neuronal repair. The concept of triphasic ODS is first being described in our series.
© 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  central pontine myelinolysis (CPM); dystonia; extrapontine myelinolysis (EPM); osmotic demyelination syndrome (ODS); parkinsonism; triphasic course

Year:  2021        PMID: 34405095      PMCID: PMC8354067          DOI: 10.1002/mdc3.13250

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  30 in total

1.  Akinetic-rigid syndrome due to extrapontine and pontine myelinolysis following appropriate correction of hyponatraemia.

Authors:  Aaron de Souza
Journal:  J Clin Neurosci       Date:  2011-01-26       Impact factor: 1.961

Review 2.  Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes.

Authors:  R J Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 3.  Central and extrapontine myelinolysis: then...and now.

Authors:  B K Kleinschmidt-Demasters; Amyn M Rojiani; Christopher M Filley
Journal:  J Neuropathol Exp Neurol       Date:  2006-01       Impact factor: 3.685

Review 4.  Central pontine and extrapontine myelinolysis: a systematic review.

Authors:  T D Singh; J E Fugate; A A Rabinstein
Journal:  Eur J Neurol       Date:  2014-09-15       Impact factor: 6.089

Review 5.  Central pontine and extrapontine myelinolysis: a report of 58 cases.

Authors:  A Gocht; H J Colmant
Journal:  Clin Neuropathol       Date:  1987 Nov-Dec       Impact factor: 1.368

6.  Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.

Authors:  Aaron de Souza; Rainha J de Souza
Journal:  Parkinsonism Relat Disord       Date:  2017-07-12       Impact factor: 4.891

Review 7.  Hyponatremia: A Review.

Authors:  Mary Ansley Buffington; Kenneth Abreo
Journal:  J Intensive Care Med       Date:  2015-01-14       Impact factor: 3.510

8.  Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients.

Authors:  Ramesha Nekkare Kallakatta; Ashalatha Radhakrishnan; R K Fayaz; J P Unnikrishnan; Chandrasekharan Kesavadas; Sankara P Sarma
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-08       Impact factor: 10.154

Review 9.  Movement disorders and the osmotic demyelination syndrome.

Authors:  Aaron de Souza
Journal:  Parkinsonism Relat Disord       Date:  2013-05-07       Impact factor: 4.891

10.  FDG PET/CT with SPM Analysis in Early Diagnosis of Clinically Suspected Osmotic Demyelination Syndrome with Non-contributory MRI.

Authors:  Nikhil Seniaray; Ritu Verma; Rajeev Ranjan; Ethel Belho; Dharmender Malik; Vanshika Gupta; Abhinav Jaimini; Harsh Mahajan
Journal:  Indian J Nucl Med       Date:  2019 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.